Medical Journals Mull Hedge Fund Disclosures

Jan 20 2011 | 2:59am ET

More than a dozen top medical research journals are to consider requiring authors to disclose payments from hedge funds and other investment firms.

The move by the New England Journal of Medicine, Journal of the American Medical Association, The Lancet and 11 other publications follows the arrest of a doctor for allegedly passing confidential information about a drug trial to hedge fund FrontPoint Partners. Yves Benhamou was an adviser to the drug market, Human Genome Sciences, as well as to several hedge funds.

The 14 members of the International Committee of Medical Journal Editors will discuss a possible disclosure requirement at their annual meeting in June. Researchers are already required to disclose financial relationships with drug and medical device makers.

Medical journals are scoured by health-care investors, and articles can have a major impact on the market.


In Depth

Debunking Conventional Investment Wisdom

Feb 8 2017 | 3:22pm ET

Due diligence in the hedge fund world has long involved some combination of the...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Future of Private Equity: New Opportunities, New Challenges

Feb 3 2017 | 6:41pm ET

The private equity industry’s astonishing rebound since the financial crisis has...

 

From the current issue of